Live from the NIH registry
Studies recruiting near Shreveport right now
Top 25 of 166 recruiting studies, sorted by proximity — each links to its official registry page
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Ochsner LSU Health Shreveport - Regional Urology — Shreveport, Louisiana (4.9 mi)
· Sponsor: Urotronic Inc.
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Obesity
N/A
Interventional 522 participants sought
David Raines Community Health Center - Shreveport Clinic — Shreveport, Louisiana (4.9 mi)
· Sponsor: Tulane University
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Louisiana State University Health Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medical University of South Carolina
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Louisiana Research Center - GastroIntestinal Associates — Shreveport, Louisiana (4.9 mi)
· Sponsor: Hoffmann-La Roche
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12169 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
TRIALS 365 ( Site 6005) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Willis-Knighton Medical and Cancer Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: NRG Oncology
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Wake Forest University Health Sciences
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Overactive Bladder, Urge Incontinence
N/A
Interventional 200 participants sought
Louisiana State University Health Sciences Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Valencia Technologies Corporation
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Lupus Nephritis
Phase 2
Interventional 40 participants sought
Louisiana State University — Shreveport, Louisiana (4.9 mi)
· Sponsor: Hoffmann-La Roche
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Phase 3
Interventional 1,630 participants sought
Trials 365 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eli Lilly and Company
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Peripartum Cardiomyopathy, Postpartum
Phase 4
Interventional 250 participants sought
Louisiana State University — Shreveport, Louisiana (4.9 mi)
· Sponsor: Dennis M. McNamara, MD, MS
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
N/A
Observational 100 participants sought
Ochsner LSU Health Science Center Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Innoviva Specialty Therapeutics
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: NRG Oncology
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Phase 3
Interventional 660 participants sought
Trials365, LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Genmab
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Akero Therapeutics, Inc
STimulation to Activate RespIration
ARDS (Moderate or Severe), AHRF
N/A
Interventional 30 participants sought
Louisiana State University Health Sciences — Shreveport, Louisiana (4.9 mi)
· Sponsor: Lungpacer Medical Inc.
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 04 — Bossier City, Louisiana (5.1 mi)
· Sponsor: TR Therapeutics
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sickle Cell Disease
Phase 3
Interventional 192 participants sought
Louisiana State University Health Sciences Center - Shreveport- Site Number : 8400037 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Sanofi
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease
Phase 2
Interventional 136 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Malignant Neoplasm
Phase 2
Interventional 250 participants sought
TRIALS 365 ( Site 0022) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Daiichi Sankyo
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: National Cancer Institute (NCI)